The need for a dose constraint in hip prosthesis to minimize later hip dysfunction. A retrospective analysis of relevant cases.
Med Dosim
; 46(3): 279-282, 2021.
Article
en En
| MEDLINE
| ID: mdl-33741221
ABSTRACT
Results from a single-institution study support the need of a dose constraint for patients who have previously undergone hip replacement surgery. Our study provides evidence that a dose above 30 Gy to the area of hip prosthesis is significantly correlated with later hip arthroplasty dysfunction as measured by the Harris Hip Score. As total hip arthroplasty becomes more and more common, it is urgent to further look into radiation therapy treatment parameters that can be modified to improve the quality of life of patients who receive pelvic irradiation after hip arthroplasty. Further prospective studies are needed to extract safe conclusions.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Artroplastia de Reemplazo de Cadera
/
Prótesis de Cadera
Tipo de estudio:
Observational_studies
Límite:
Humans
Idioma:
En
Revista:
Med Dosim
Asunto de la revista:
RADIOTERAPIA
Año:
2021
Tipo del documento:
Article
País de afiliación:
Grecia